Results: At baseline, there were minimal signs and symptoms. Maximum mean hyperemia with CAPT was 2.3 6 0.6 units (between moderate and severe) and with EEC was 1.9 6 0.5 units (approximately moderate); these maxima occurred after 30 minutes with CAPT (rapid spike) and after 180 minutes with EEC (gradual increase). Mean swelling was ,1 unit out of 4 units at all times (CAPT and EEC), and mucous discharge was observed in only 1 subject during the study (with CAPT). Maximum mean itching with both CAPT and EEC was 2.8 6 1.0 units (approximately severe), but this maximum occurred after 20 minutes with CAPT (rapid spike) and after 180 minutes with EEC (gradual increase). Maximum mean tearing with CAPT was 1.2 6 0.7 units (approximately mild) and with EEC was 1.6 6 0.6 units (between mild and moderate); these maxima occurred after 15 minutes with EEC (rapid spike) and after 120 minutes with EEC (gradual increase). Conclusions: The time courses of allergic signs and symptoms differed between CAPT and EEC models; however, both models evoked similar maximum response levels. This demonstrates that the EEC model is a useful challenge model for mimicking natural airborne ocular allergen exposure. Background: Allergic conjunctivitis (AC) is one of the most common eye disorders in clinical practice. It has been shown that AC is a disorder mediated by Th2 lymphocytes producing IL-4 and IL-5, where the eye damage is caused by a type I hypersensitivity. It has been suggested in asthma and rhinitis that T regulatory cells (Tregs) CD4 1 CD25 1 FOXP3 1 have been involved in control allergic status, favoring an optimal microenvironment with immunosuppressive cytokines (IL-10, TGF-b). However is unknown if Tregs have a role in human allergic conjunctivitis, thus it was the aim of this study. Methods: Peripheral blood mononuclear cells (PBMC) were isolated from blood samples of healthy donors (HD) and AC-patients, and then PBMC were labeled with mAbs against CD4, CD25 and FOXP3. Labeled cells were analyzed by flow cytometry. Statistical analysis was performed with GraphPad v.5. Results: AC-patients showed 55-times more CD4 1 CD25 1 cells than HD (P ¼ 0.02). Most of CD4 1 CD25 1 were FOXP3 -(90 6 5.4), when we compared MFI of FOXP3 in CD4 1 CD25 1 cells, we observed a decreased expression in AC-patients than HD (28.5 vs 85.36, P ¼ 0.02). Conclusions: Despite we observed higher frequency of CD4 1 CD25 1 in ACpatients, these cells were FOXP3 2 , more interesting, the few cells FOXP3 1 showed a diminished MFI. These data suggest that allergic conjunctivitis status could be related with a regulatory dysfunction, as has been suggested in asthma and rhinitis. Background: Allergic conjunctivitis is one of the most common diseases affecting the ocular surface, it has been suggested that T CD41 cells regulate immune response in allergic diseases such as asthma and rhinitis, in a predominant Th2 response. In animal models, it has been observed a selective migration of CD41 T cells to conjunctiva directed by chemokines; however molecules involved in CD41 T cell migration in humans is unknown, thus it was the aim of this study. Methods: Peripheral blood mononuclear cells (PBMC) were isolated from blood samples of healthy donors (HD) and AC-patients. PBMC were labeled with mAbs against CD4, CCR4, CCR5, and CRR9, and then labeled cells were analyzed by flow cytometry. T test was used to perform statistical analysis, P , 0.05 were considered statistically significant. Results: We observed increased frequency of CCR41 and CCR91 on PBMC cells; interestingly, expression of CCR41 was 1.46 times increased on CD41 T cells of AC-patients compared to CD41 T cells of HD (P ¼ 0.01). Similarly, we observed higher frequency of CCR9 expression on CD41 cells of AC-patients than on CD41 T cells of HD (P ¼ 0.01). On the other hand, CCR5 expression was diminished on PBMC from ACpatients than in HD (P ¼ 0.0002). Conclusions: Increased frequency of CD41 CCR41 CCR91 was observed in AC patients with diminished frequency of CCR5 expression on PBMC. CCR4 and CCR9 have been involved in inflammatory process such arthritis and asthma, both could be related to inflammatory reaction at conjunctiva. CCR5 expression is mainly on Th1 cells, diminished frequency on PBMC in allergic conjunctivitis patients could be related with imbalance of immune response favoring a Th2 chronic inflammation. Department of Ophthalmology, Tsurumi University Dental Hospital, Kanagawa, Japan. Background: Interferon-g (IFN-g) is a T helper type 1 (Th1) cytokine which has antiviral, anti-proliferative, and immunomodulatory properties. Despite the presence of IFN-g in the conjunctiva or tear fluid of patients with severe allergic conjunctivitis, the role of IFN-g in allergic conjunctivitis is controversial and enigmatic. In this study, we assess the effect of long-term treatment of IFN-g on human conjuctival fibroblasts. Methods: Primary cultured fibroblasts derived from human conjunctiva specimens were established. Cultured fibroblasts were incubated with or without IFN-g (10 ng/mL) for up to 14 days. After IFN-g treatment, cells were washed out and were re-stimulated with combinations of IL-4 (10 ng/mL) and TNFa (10 ng/mL) for 6 hours. Then, total mRNAs were isolated and mRNA expression levels were measured using a microarray and real time-PCR. Results: In IFN-g treated fibroblasts in short-term (6 hours), we confirmed the increased expression levels of well-known interferon induced genes, such as MHC class II, IRF1 and CXCL10. Increased expression of CCL11 stimulated by IL-4 1 TNFa was suppressed by short-term IFN-g treatment as described previously. In long-term (14 days) IFN-g treated cells, the expression of CCL11 and several proinflammatory chemokines, which were associated with Th2 cell and eosinophil migration, was slightly but significantly increased without any other stimulations. Interestingly, IL-4 1 TNFa stimulation greatly enhanced the expression levels of these chemokines, suggesting that long-term IFN-g treatment alters the competency of gene expression potential on these gene loci in contrast to the situation for short term treatment. Time-course analysis of IFN-g
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